N. Hashimoto

发表

Characteristics of non‐alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign

M. Taniai, K. Kodama, K. Tokushige, 2019, Journal of gastroenterology and hepatology.

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

K. Ueno, N. Hashimoto, S. Yano, 2006, Biological & pharmaceutical bulletin.

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)

L. Newby, K. Yokote, M. Takemoto, 2020, Journal of diabetes investigation.

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

L. Newby, K. Yokote, M. Takemoto, 2019, Diabetes, obesity & metabolism.

Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.

Yoshifumi Suzuki, N. Hashimoto, J. Ogino, 2016, Endocrine journal.

Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, Ameliorates Nonalcoholic Fatty Liver Disease in Japanese Patients with Type 2 Diabetes Mellitus

N. Hashimoto, J. Ogino, Kanako Tashima, 2019 .

Moyamoya disease complicated by Graves’ disease and type 2 diabetes mellitus: Report of two cases

T. Kawamata, Sakiko Suzuki, N. Hashimoto, 2011, Clinical Neurology and Neurosurgery.

Sex Differences in Coronary Artery Calcification Score and its Use as a Predictor of Progression of Diabetic Nephropathy in Japanese Patients with Type 2 Diabetes Mellitus

N. Hashimoto, Aiko Toyonaga, J. Ogino, 2018 .

Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses.

S. Kushida, J. Kanda, Kazutoshi Sato, 2006, Metabolism: clinical and experimental.

Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening.

I. Komuro, Katsuya Yoshida, N. Funabashi, 2009, International journal of cardiology.

Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2018, Diabetology International.

Analysis of the effect of seasonal administration on the efficacy of sitagliptin: Subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes Study

Taku Kudo, H. Sakura, Y. Iwamoto, 2018, Journal of diabetes investigation.

Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Taku Kudo, H. Sakura, Y. Iwamoto, 2016, BMC Endocrine Disorders.

Hyperferritinemia Is a Predictor of Onset of Diabetes in Japanese Males Independently of Decreased Renal Function and Fatty Liver: A Fifteen-Year Follow-Up Study

Yoshifumi Suzuki, N. Hashimoto, Yasunori Sato, 2021, Journal of clinical medicine research.

Sex differences in predictive factors for onset of type 2 diabetes in Japanese individuals: A 15‐year follow‐up study

Yoshifumi Suzuki, T. Babazono, N. Hashimoto, 2022, Journal of diabetes investigation.

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor sitagliptin compared with α‐glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS‐2): a multicenter, randomized, open‐label, non‐inferiority trial

A. Kanatsuka, K. Sakurai, M. Takemoto, 2014, Diabetes, obesity & metabolism.

Idiopathic bilateral adrenal haemorrhage related to acute adrenal insufficiency

N. Hashimoto, J. Ogino, J. Toda, 2013, BMJ Case Reports.

[A case of corpus callosum splenium encephalopathy and 2009 influenza A/H1N1].

M. Terai, N. Hashimoto, H. Hamada, 2011, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Renal Function During an Open-Label Prospective Observational Trial of Sitagliptin in Patients With Diabetes: A Sub-Analysis of the JAMP Study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2017, Journal of clinical medicine research.

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study

H. Sakura, Y. Iwamoto, O. Tomonaga, 2017, Diabetology International.

An autopsy case of macroglobulinemia complicated with syndrome of inappropriate secretion of ADH (SIADH) like hyponatremia, hypopituitarism and AL amyloidosis.

K. Hiroshima, N. Hashimoto, Aiko Toyonaga, 2014, Endocrine journal.

Pituitary apoplexy after surgical treatment of lung cancer.

Y. Sekine, M. Yoshino, E. Koh, 2014, The Annals of thoracic surgery.

Increased prevalence of diabetic complications in Japanese patients with type 1 diabetes and nonalcoholic fatty liver disease

Yoshifumi Suzuki, N. Hashimoto, H. Matsuura, 2012, Diabetology International.

Abstract 5825: Association between Patterns of FDG Uptake and Arterial Wall Calcification on PET/CT and Atherogenic Risk Factors in Healthy Subjects

I. Komuro, Katsuya Yoshida, N. Funabashi, 2008 .

Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study)

I. Tatsuno, K. Yokote, M. Takemoto, 2017, BMJ Open.

Moyamoya disease complicated by Graves’ disease and type 2 diabetes mellitus: Report of two cases

T. Kawamata, Sakiko Suzuki, N. Hashimoto, 2011, Clinical Neurology and Neurosurgery.